P-240 Frequency and management of trifluridine/tipiracil (FTD/TPI) + bevacizumab (BEV)-associated neutropenia in patients with refractory metastatic colorectal cancer (mCRC) in real-world practice

Saved in:
Bibliographic Details
Published inAnnals of oncology Vol. 34; pp. S100 - S101
Main Authors Lago, N. Martínez, Rendo, C. Reboredo, Chucla, T. Calleja, Salvador, M. Mateos, Fernandez, F. Busto, Gómez, J. de la Cámara, Reboredo-Lopez, M.
Format Journal Article
LanguageEnglish
Published Elsevier Ltd 01.06.2023
Online AccessGet full text

Cover

More Information
ISSN:0923-7534
1569-8041
DOI:10.1016/j.annonc.2023.04.296